ADVFN Logo ADVFN

Wir konnten keine Ergebnisse für:
Stelle sicher, dass deine Schreibweise korrekt ist oder versuche deine Suche zu erweitern.

Trends

Toplisten

Es scheint, dass du nicht eingeloggt bist.
Klicke auf den Button unten, um dich einzuloggen und deine zuletzt angesehenen Aktien zu sehen.

Hot Features

Registration Strip Icon for monitor Überwachen Sie mehrere Echtzeitkurse von führenden Börsen wie NASDAQ, NYSE, AMEX, Bovespa und mehr.

BTAI BioXcel Therapeutics Inc

2,57
0,01 (0,39%)
04 Mai 2024 - Geschlossen
Verzögert um 15 Minuten
Name Symbol Markt Aktientyp
BioXcel Therapeutics Inc BTAI NASDAQ Common Stock
  Änderung Änderung % Aktuell Zeit
0,01 0,39% 2,57 02:00:00
Handelsbeginn Niedrig Hoch Schlusskurs Handelsende
2,60 2,56 2,6701 2,57 2,56
more quote information »

Aktuelle News

Datum Zeit Quelle Überschrift
25.4.202413:00GLOBEBioXcel Therapeutics to Report First Quarter 2024 Financial..
24.4.202416:30GLOBEBioXcel Therapeutics Announces Late-Breaking Abstract on..
22.4.202413:00GLOBEBioXcel Therapeutics Announces Plan for Evaluating BXCL501..
10.4.202413:00GLOBEBioXcel Therapeutics Announces TRANQUILITY In-Care Pivotal..
25.3.202412:00GLOBEBioXcel Therapeutics Announces $25 Million Registered Direct..
15.3.202412:00GLOBEBioXcel Therapeutics Announces European Patent Office’s..
12.3.202412:00GLOBEBioXcel Therapeutics Reports Financial Results for the..
01.3.202413:00GLOBEBioXcel Therapeutics to Report Fourth Quarter and Full Year..
14.2.202413:00EDGAR2Form 8-K - Current report
13.2.202415:00GLOBEBioXcel Therapeutics Announces Termination of Proposed..
12.2.202418:45EDGAR2Form 8-K - Current report
12.2.202413:14GLOBEBioXcel Therapeutics Receives FDA Fast Track Designation for..
08.2.202423:27EDGAR2Form 424B5 - Prospectus [Rule 424(b)(5)]
08.2.202422:53EDGAR2Form 8-K - Current report
08.2.202422:01GLOBEBioXcel Therapeutics Announces Proposed Public Offering
08.2.202413:08EDGAR2Form 8-K - Current report
06.2.202413:00GLOBEBioXcel Therapeutics Announces Completion of Patient..
05.2.202413:00GLOBEBioXcel Therapeutics Announces USPTO’s Allowance of Patent..
23.1.202406:15EDGAR2Form EFFECT - Notice of Effectiveness
12.1.202422:16EDGAR2Form S-3 - Registration statement under Securities Act of..
18.12.202322:57EDGAR2Form 4 - Statement of changes in beneficial ownership of..
18.12.202322:55EDGAR2Form 4 - Statement of changes in beneficial ownership of..
18.12.202322:54EDGAR2Form 4 - Statement of changes in beneficial ownership of..
18.12.202313:22EDGAR2Form 8-K - Current report
12.12.202313:00EDGAR2Form 8-K - Current report
12.12.202313:00GLOBEBioXcel Therapeutics Hosting Virtual Neuroscience R&D Day..
11.12.202313:00GLOBEBioXcel Therapeutics Strengthens Clinical Development..
06.12.202313:00EDGAR2Form 8-K - Current report
30.11.202313:00GLOBEBioXcel Therapeutics to Host Virtual Neuroscience R&D Day on..
13.11.202317:59EDGAR2Form RW WD - Withdrawal of Registration Withdrawal Request
13.11.202316:23EDGAR2Form RW - Registration Withdrawal Request
08.11.202313:00GLOBEBioXcel Therapeutics Reports Positive Overall Survival..
06.11.202313:00GLOBEBioXcel Therapeutics Announces Update on NIDA-funded Trial..
02.11.202311:01EDGAR2Form S-3 - Registration statement under Securities Act of..
31.10.202312:00GLOBEBioXcel Therapeutics to Report Third Quarter 2023 Financial..
30.10.202312:00GLOBEBioXcel Therapeutics Receives Permanent J-Code for IGALMI™..
25.10.202316:30APSStrong Open For Biotech Shares Following Phase 3 Comments
25.10.202313:00GLOBEBioXcel Therapeutics Announces Positive Findings from..
19.10.202322:48EDGAR2Form SC 13G/A - Statement of acquisition of beneficial..
10.10.202313:06EDGAR2Form 8-K - Current report
10.10.202313:00GLOBEBioXcel Therapeutics Reports Positive Overall Survival..
04.10.202313:05EDGAR2Form 8-K - Current report
04.10.202313:00GLOBEBioXcel Therapeutics Provides Update on Recent Developments..
25.9.202323:07EDGAR2Form 8-K - Current report
20.9.202317:21EDGAR2Form 144 - Report of proposed sale of securities
20.9.202317:15EDGAR2Form 144 - Report of proposed sale of securities
19.9.202314:00EDGAR2Form 8-K - Current report
18.9.202322:49EDGAR2Form 4 - Statement of changes in beneficial ownership of..
18.9.202322:48EDGAR2Form 4 - Statement of changes in beneficial ownership of..
18.9.202322:47EDGAR2Form 4 - Statement of changes in beneficial ownership of..

Kürzlich von Ihnen besucht

Delayed Upgrade Clock